Aimmune Therapeutics (Aimmune Therapeutics) EBITDA Margin % : 0.00% (As of Jun. 2020)

Aimmune Therapeutics EBITDA Margin % Chart

Aimmune Therapeutics Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-14,397.57	-

Competitive Comparison of Aimmune Therapeutics's EBITDA Margin %

For the Biotechnology subindustry, Aimmune Therapeutics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aimmune Therapeutics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aimmune Therapeutics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aimmune Therapeutics's EBITDA Margin % falls into.

Aimmune Therapeutics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aimmune Therapeutics's EBITDA Margin % for the fiscal year that ended in Dec. 2019 is calculated as

Aimmune Therapeutics's EBITDA Margin % for the quarter that ended in Jun. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aimmune Therapeutics  (NAS:AIMT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Aimmune Therapeutics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Aimmune Therapeutics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aimmune Therapeutics (Aimmune Therapeutics) Business Description